| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692738 | The Breast | 2017 | 7 Pages |
Abstract
There are many options and still unanswered questions related to extended ET, which are discussed in this review. The most important issue in deciding prolonged duration of ET is undoubtfully how to identify ER+ patients who benefit most from this approach. With this purpose, not only classical pathological factors have been studied, but also molecular profiles of individual tumors, which might help us in the near future to better tailor ET. Not only efficacy, but also toxicity of such prolonged treatment is essential for optimal use, particularly maintained compliance in a routine clinical practice. These issues are discussed in this review.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Domen Ribnikar, Berta Sousa, Tanja Cufer, Fatima Cardoso,